| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967828 | Vaccine | 2012 | 7 Pages |
Abstract
⺠One dose of zoster vaccine (ZV) elicits substantial protection against HZ. ⺠This study examined impact of a second dose of ZV. ⺠ZV was generally well-tolerated and immunogenic in adults â¥60 years old. ⺠2nd dose of ZV was generally safe, but did not boost VZV-specific immunity beyond postdose 1 levels.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Joost N. Vermeulen, Joep M.A. Lange, Stephen K. Tyring, Patrick H. Peters, Margaret Nunez, Gregory Poland, Myron J. Levin, Carrie Freeman, Ira Chalikonda, Jianjun Li, Jeffrey G. Smith, Michael J. Caulfield, Jon E. Stek, Ivan S.F. Chan, Rupert Vessey,